StemLift® Stem Cell Therapy for Anti-Aging and Longevity
Healthy Aging Through Regenerative Medicine
Physician-supervised UC-MSC and exosome protocols designed to support cellular health, skin quality, and systemic function as part of a science-informed approach to healthy aging and longevity.
Rediscovering youth and vitality through stem cell therapies
StemLift® is a physician-supervised regenerative protocol using Umbilical Cord Mesenchymal Stromal Cells (UC-MSC) and UC-MSC-derived exosomes to support skin tissue health as part of a broader approach to healthy aging.
As an anti-aging stem cell treatment, it is delivered through intradermal and supportive topical application, no surgical procedures, no incisions, no general anesthesia. Results are individual and assessed through ongoing clinical evaluation.
Collagen and Elastin Support
May support collagen signaling pathways associated with skin structure
Skin Structure Support
Aims to support skin firmness and skin elasticity by engaging collagen-related signaling.
Non-surgical Procedure
No incisions or anesthesia required, minimal downtime, and a quicker return to normal activity.
Regenerative Medicine for Anti-aging
Chronic low-grade inflammation, sometimes described as inflammaging, is recognized as a contributor to accelerated cellular aging. The StemLift® protocol, combined with the Total Body I.V. UC-MSC treatment and the NeuroBoost® exosome nebulization protocol, is designed to support anti-inflammatory signaling both systemically and at the dermal level.
The approach aims to create a biological environment that may support healthier tissue function over time. Individual outcomes vary and are discussed during clinical consultation.
Enhance Facial Skin Collagen Synthesis Reduced collagen synthesis and increased collagen breakdown are recognized features of skin aging. Emerging research suggests UC-MSC-derived therapies may support collagen synthesis pathways in the skin. Individual responses vary; for supporting scientific references, visit our Resource Center.
Deep Facial Cleansing and Hydration
The StemLift® protocol includes a dermatological treatment that supports the regenerative component of the facial protocol.
Facial Cleansing
A series of cleansing steps, enriched with a hydrating treatment that exfoliates and nourishes the skin.
UC-MSC Exosomes Application
The intradermal application of UC-MSC-derived exosomes is designed to support tissue repair signaling and may contribute to collagen and elastin synthesis over time. Responses are individual and develop gradually.
Platelet-enriched Blood Plasma PRGF
Combined with UC-MSC-derived exosomes, platelet-rich plasma may support collagen signaling and contribute to improved skin texture and hydration as part of the overall protocol.
How StemLift® Compares to Other Anti-Aging Treatments
Patients researching exosome therapy for skin are usually weighing it against treatments they’ve already had or been offered. The core distinction: most aesthetic treatments either paralyze muscle, add volume, or create controlled injury. StemLift® works through signaling.
| Approach | What it does | Best suited for | Downtime |
|---|---|---|---|
| Botox / neuromodulators | Temporarily relaxes muscle to soften expression lines | Dynamic fine lines and wrinkles | None |
| Dermal fillers (hyaluronic acid) | Adds volume beneath the skin | Volume loss, structural contouring | Days |
| Laser resurfacing / energy-based | Creates controlled thermal injury to trigger a repair response | Texture, pigmentation, moderate laxity | Days to weeks |
| Microneedling (± PRP) | Creates controlled micro-injury to stimulate collagen | Texture, mild laxity | Days |
| StemLift® (UC-MSC + exosomes) | Delivers regenerative signaling to the dermal environment | Patients seeking skin-quality support without volumizers | Minimal |
| Surgical facelift | Structural repositioning of tissue | Advanced laxity | Weeks |
StemLift® is not positioned as a replacement for any of these. Many patients combine approaches, a neuromodulator for expression lines alongside a regenerative protocol for skin quality is a common pattern, and the physician team will discuss sequencing if you’re already using other treatments.
Am I a candidate? Suitability depends on skin condition, age, medical history, prior aesthetic treatments, and treatment goals. StemLift® supports skin quality; it does not add volume or reposition tissue, so patients whose primary concern is advanced laxity or significant volume loss may be better served by other approaches, and the medical team will say so during evaluation.
Cellular Health, Longevity, and Systemic Support
Aging isn’t one process. It’s several overlapping ones, chronic low-grade inflammation, declining cellular repair capacity, accumulating cellular senescence, and reduced regenerative signaling across tissues. Regenerative medicine for longevity targets that biology rather than its cosmetic outputs.
UC-MSC and exosome therapies are being studied for their role in supporting cellular homeostasis, the maintenance of stable biological function across tissues.
Systemic Delivery
The Total Body I.V. UC-MSC protocol is designed to deliver cells systemically rather than to a single target tissue, the difference between treating a site and supporting an environment.
Inflammatory Signaling Inflammaging
Persistent low-grade inflammation associated with aging is one of the more consistently documented findings in aging research. UC-MSC anti-inflammatory signaling is the mechanism most directly relevant to it.
Cross-Protocol Coordination
Healthy aging protocols are frequently combined: StemLift® for skin, NeuroBoost® for cognitive support, StemGrow® for scalp and hair, sexual wellness protocols where relevant. Combinations are designed by the physician team based on clinical profile, and each component is evaluated separately for suitability.
Why Patients Travel for Regenerative Longevity Protocols
Allogeneic UC-MSC protocols of this kind are not currently available through US clinics. Patients pursuing them travel to a physician-supervised, government-regulated facility rather than relying on domestic providers offering diluted or off-label alternatives. OmniStem’s facility in Punta Cana, Dominican Republic is approximately 90 minutes by air from Miami, with direct flights from major Eastern US cities.
Frequently Asked Questions
Stem Cell Therapy for Anti-Aging and Longevity
Inflammation, cellular repair, tissue function. The biology under the surface, reviewed by a physician.
Your case.
In our hands.
Within 48 hours.
A physician on the OmniStem medical team will review your clinical profile and prepare an initial assessment. What follows is a medical conversation.
Your clinical profile 2 MIN
A brief summary of your health context. The medical team uses this to prepare before your first conversation.
Physician review 48 H
Dr. Montoya or a member of the medical team evaluates your profile individually.
A clinical conversation
Your history, your priorities, and what a protocol designed around your clinical profile might include.
No obligation
The case review is informational. The only timeline that matters is yours.
Step 1
A few questions to begin
These help the medical team understand whether OmniStem’s protocols are appropriate for your situation before we speak.